Products for Research Use Only
RegisterLogin

EGFR-IN-107

CAT: 0804-HY-163396Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-163396Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
EGFR-IN-107 (compound 3r) is an orally active EGFR inhibitor with IC50 values of 0.4333 μM for EGFRWT and 0.0438 μM for EGFRL858R/T790M. EGFR-IN-107 has anti-proliferative activity and can inhibit the proliferation of H1975 cells and induce their apoptosis. EGFR-IN-107 can be used in cancer research[1].
UNSPSC
12352005
Target
Apoptosis; EGFR
Type
Reference compound
Related Pathways
Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-107.html
Solubility
10 mM in DMSO
Smiles
C=CC(NC1=C(C=C(C(NC2=NC(C3=C(N(C4=C3C=CC=C4)C)C5=CC=CC(F)=C5)=CC=N2)=C1)OC)N(CCN(C)C)C)=O
Molecular Formula
C34H36FN7O2
Molecular Weight
593.69
References & Citations
[1]Feng R, et al. Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs. Sci Adv. 2024 Mar 8;10 (10) :eadl0026.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P991328MAb604.107
HY-P10692HB-107
HY-106806NZ-107
HY-P991272-01ATR-107
HY-167893AGH-107
HY-108038-01ABT-107
HY-126763ATI22-107
HY-168649-01JH-LPH-107
HY-149896Antitumor agent-107
HY-147546Antibacterial agent 107

Alternative Products

CatalogName
T209547-01EGFR-IN-107
T201735-01AGH-107
T9901A-1007-01ATR-107
GTR19240838-01TJA-107
GTR19233371-01TR-107
GTR19274275-01α-Glucosidase-IN-107
BA6827-10ABT-107
T9901A-1601-01MAb604.107
TP2932-01HB-107
MBS131174-01NM-107

Popular Products